Holen Sie sich die Stockscreener-App
318.46
0.08%
0.25
Handel nachbörslich:
318.46
Penumbra Inc Aktie (PEN) Neueste Nachrichten
CE Mark Granted to Penumbra's CAVT Platform - dicardiology.com
Penumbra (PEN) Achieves CE Mark for Thunderbolt Technology - GuruFocus
Penumbra expands CAVT for stroke into Europe with Thunderbolt CE mark - NeuroNews International
Penumbra earns CE mark for Thunderbolt thrombectomy system - MassDevice
Penumbra’s Thunderbolt Computer-Assisted Vacuum Thrombectomy Earns CE Mark - Medical Product Outsourcing
Penumbra Inc Expands Cavt For Stroke To Europe With CE Mark For Thunderbolt - TradingView
Penumbra secures CE Mark for stroke treatment device in Europe - Investing.com
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT - PR Newswire
Boston Scientific Eyes Neurovascular Growth With Penumbra Thunderbolt Clearance - Yahoo Finance UK
Penumbra CAVT Platform Receives FDA Clearance - dicardiology.com
FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke - Yahoo Finance
FDA OKs Penumbra’s Thunderbolt Computer-Assisted Vacuum Thrombectomy for Stroke - Medical Product Outsourcing
Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference - GuruFocus
Penumbra wins FDA clearance for Thunderbolt computer-assisted vacuum thrombectomy for stroke - MassDevice
Penumbra (PEN) Receives FDA Clearance for Innovative Thrombectom - GuruFocus
Penumbra receives FDA clearance for stroke treatment device By Investing.com - Investing.com Australia
Penumbra receives FDA clearance for stroke treatment device - Investing.com
Computer-guided THUNDERBOLT device designed to speed stroke clot removal - Stock Titan
Penumbra, Inc. to Present at the 41st Annual J.P. Morgan Healthc - GuruFocus
(PEN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Investor Outlook: Penumbra, Inc. (PEN) Boasts 13.36% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Total operating expenses of Penumbra, Inc. – XETR:0P8 - TradingView
Tangible book value per share of Penumbra, Inc. – XETR:0P8 - TradingView
Non-controlling/minority interest of Penumbra, Inc. – XETR:0P8 - TradingView
Penumbra, Inc. Cash Flow – XETR:0P8 - TradingView
Penumbra, Inc. Balance Sheet – XETR:0P8 - TradingView
PEN Technical Analysis & Stock Price Forecast - Intellectia AI
Why Is Penumbra (PEN) Down 1.2% Since Last Earnings Report? - Yahoo Finance
Here’s What Supports Penumbra’s (PEN) Revenue Growth and Margin Expansion - Insider Monkey
Grewal Harpreet, Penumbra director, sells $32,822 in stock - Investing.com
JP Morgan Upgrades Penumbra (PEN) - MSN
Penumbra Class Action Reminder - TMX Newsfile
Penumbra, Inc. (PEN) Stock Analysis: A Look At Growth Potential With A 14% Upside - DirectorsTalk Interviews
Decagon Asset Management LLP's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra Shareholder Notice - TMX Newsfile
Penumbra Shareholder Alert - TMX Newsfile
(PEN) Risk Channels and Responsive Allocation - Stock Traders Daily
RTW INVESTMENTS, LP's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra Inc stock (US70975L1070): shares steady after recent pullback as valuation comes into focus - AD HOC NEWS
Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Giant With A 10.55% Upside Potential - DirectorsTalk Interviews
Neurovascular Devices Market Size, Share Growth Report 2034 - Fortune Business Insights
Water Island Event-Driven Fund's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra stock hits 52-week high at $328.69 By Investing.com - Investing.com Australia
Penumbra stock hits 52-week high at $328.69 - Investing.com
Penumbra (PEN) CEO-linked trust donates 77,000 shares in charitable stock gift - Stock Titan
Fortress Investment Group LLC's Penumbra Inc(PEN) Holding History - GuruFocus
Peripheral Embolization Coils Market is experiencing boost - openPR.com
PEN Stock Price, Quote & Chart | PENUMBRA INC (NYSE:PEN) - ChartMill
(PEN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
ServisFirst Gets Axed by Champlain — a Minor Position in a Major Drawdown - The Motley Fool
HBK INVESTMENTS L P's Penumbra Inc(PEN) Holding History - GuruFocus
120,815 Shares in Penumbra, Inc. $PEN Purchased by Stephens Investment Management Group LLC - MarketBeat
Thrivent Financial for Lutherans Sells 72,330 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. (NYSE:PEN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Penumbra, Inc. (PEN) Stock Analysis: Navigating a 12.76% Upside in the Medical Devices Sector - DirectorsTalk Interviews
PEN (Penumbra) Q1 earnings miss by 24% as stock shows surprising resilience, down just 0.16% today. - newsline.com
Penumbra, Inc. Reports Third Quarter 2025 Financial Results - Quantisnow
Penumbra Shareholders Approve Merger with Boston Scientific - The Globe and Mail
Penumbra revenue up 15.6% to USD 374.8M in Q1 2026 - Medical Buyer
PEN Maintained by Citigroup -- Price Target Lowered to $350 - GuruFocus
Penumbra (PEN) Margin Expansion To 11.8% Tests Bulls High P E Narrative - Sahm
Citi Maintains Penumbra(PEN.US) With Hold Rating, Cuts Target Price to $350 - Moomoo
1.21%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):